Analysis Of The Positive Influence Of Qianlie Shutong Capsule Combined With Tamsulosin On Prostate Health Of Patients With Prostatitis
Abstract
Chronic prostatitis (CP) is one of the most common health issues in the male urinary system. In this study, we included 110 patients with CP as research subjects and divided them into a research group receiving Qianlie Shutong Capsule (QLSTC) combined with tamsulosin and a control group receiving tamsulosin monotherapy. Comparing their clinical efficacy, we found that the total effective rate of treatment in the research group was higher than that in the control group (P0.05). It can be seen that QLSTC combined with tamsulosin has extremely high clinical application value in the treatment of CP and is recommended to be used clinically.
Read the paper
Related studies
- Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- A randomized, controlled trial of oral propranolol in infantile hemangioma
- Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study
- Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.